Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT04972942Phase 1Recruiting
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
T-cell Acute Lymphoblastic LeukemiaT-Cell Acute Lymphoblastic Lymphoma
StudychairStart date: 2023-05-22

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Helen DeVos Children's Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hongyu Zhang

Peking University Shenzhen Hospital, China

Moderately Similar
1 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Lymphoma
Similarity Score30%

LaQuisa Hill, MD

The Methodist Hospital Research Institute

Moderately Similar
3 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Lymphoma
Similarity Score30%

Rayne Rouce, MD

Baylor College of Medicine

Moderately Similar
3 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Lymphoma
Similarity Score30%

Rayne Rouce, MD

Pediatrics, Baylor College of Medicine

Moderately Similar
1 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Lymphoma
Similarity Score30%

Allyson Flower, MD

New York Medical College

Related
1 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Lymphoma

Worked with same sponsors:

New York Medical College
Collaborated on 1 trial
Similarity Score24%

Mitchell Cairo, MD

New York Medical College

Related
14 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic LeukemiaT-cell Acute Lymphoblastic Lymphoma

Worked with same sponsors:

New York Medical College
Collaborated on 1 trial
Similarity Score24%

Hongyu Zhang, MD/PhD

Peking University Shenzhen Hospital, China

Related
3 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic Leukemia
Similarity Score15%

Shira Dinner, MD

Northwestern University

Related
3 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic Leukemia
Similarity Score15%

Huyong Zheng, MD, PhD

Baoding Children's Hospital; Beijing Children's Hospital, Capital Medical University

Related
1 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic Leukemia
Similarity Score15%

Miriam B Garcia, DOp

UT MD Anderson

Related
1 trials

Shared therapeutic areas:

T-Cell Acute Lymphoblastic Leukemia
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04972942Phase 1StudyChair

Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma

T-cell Acute Lymphoblastic LeukemiaT-Cell Acute Lymphoblastic Lymphoma
Recruiting

All 1 trials loaded